An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis.
Adult
Aged
Anaphylaxis
/ chemically induced
Antibody Specificity
/ immunology
Biomarkers
/ metabolism
Down-Regulation
/ drug effects
Female
Humans
Immunoglobulin E
/ metabolism
Immunoglobulin G
/ metabolism
Male
Middle Aged
Myeloid Cells
/ drug effects
Neuromuscular Blocking Agents
/ pharmacology
Neutrophil Activation
/ drug effects
Platelet Activating Factor
/ metabolism
Receptors, IgG
/ metabolism
Severity of Illness Index
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
10 07 2019
10 07 2019
Historique:
received:
21
02
2018
revised:
21
12
2018
accepted:
21
05
2019
entrez:
12
7
2019
pubmed:
12
7
2019
medline:
25
7
2020
Statut:
ppublish
Résumé
Anaphylaxis is a systemic acute hypersensitivity reaction that is considered to depend on allergen-specific immunoglobulin E (IgE) antibodies and histamine release by mast cells and basophils. Nevertheless, allergen-specific IgG antibodies have been proposed to contribute when the allergen is an abundant circulating large molecule, e.g., after infusions of therapeutic antibodies or dextran. Data from animal models demonstrate a pathway involving platelet-activating factor (PAF) release by monocytes/macrophages and neutrophils activated via their Fc gamma receptors (FcγRs). We hypothesized that such a pathway may also apply to small drugs and could be responsible for non-IgE-mediated anaphylaxis and influence anaphylaxis severity in humans. We prospectively conducted a multicentric study of 86 patients with suspected anaphylaxis to neuromuscular-blocking agents (NMBAs) during general anesthesia and 86 matched controls. We found that concentrations of anti-NMBA IgG and markers of FcγR activation, PAF release, and neutrophil activation correlated with anaphylaxis severity. Neutrophils underwent degranulation and NETosis early after anaphylaxis onset, and plasma-purified anti-NMBA IgG triggered neutrophil activation ex vivo in the presence of NMBA. Neutrophil activation could also be observed in patients lacking evidence of classical IgE-dependent anaphylaxis. This study supports the existence of an IgG-neutrophil pathway in human NMBA-induced anaphylaxis, which may aggravate anaphylaxis in combination with the IgE pathway or underlie anaphylaxis in the absence of specific IgE. These results reconcile clinical and experimental data on the role of antibody classes in anaphylaxis and could inform diagnostic approaches to NMBA-induced acute hypersensitivity reactions.
Identifiants
pubmed: 31292264
pii: 11/500/eaat1479
doi: 10.1126/scitranslmed.aat1479
pii:
doi:
Substances chimiques
Biomarkers
0
Immunoglobulin G
0
Neuromuscular Blocking Agents
0
Platelet Activating Factor
0
Receptors, IgG
0
Immunoglobulin E
37341-29-0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.